Your browser doesn't support javascript.
loading
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan.
Jaswal, M; Farooq, S; Madhani, F; Noorani, S; Salahuddin, N; Amanullah, F; Khowaja, S; Safdar, N; Khan, A; Yuen, C; Keshavjee, S; Becerra, M; Hussain, H; Malik, A A.
  • Jaswal M; Department of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Farooq S; TB Control Programme, The Indus Hospital and Health Network, Karachi, Pakistan.
  • Madhani F; Programmes Unit, Aga Khan Health Services, Karachi, Pakistan.
  • Noorani S; Monitoring & Evaluation, Public Health England, London, UK.
  • Salahuddin N; TB Control Programme, The Indus Hospital and Health Network, Karachi, Pakistan.
  • Amanullah F; TB Control Programme, The Indus Hospital and Health Network, Karachi, Pakistan.
  • Khowaja S; TB Department, Interactive Research and Development (IRD) Global, Singapore.
  • Safdar N; TB Department, Interactive Research and Development (IRD) Global, Singapore.
  • Khan A; TB Department, Interactive Research and Development (IRD) Global, Singapore, TB Department, Harvard Medical School, Boston, MA, Infectious Diseases, Harvard Medical School Center for Global Health Delivery, Boston, MA.
  • Yuen C; TB Department, Harvard Medical School, Boston, MA, Infectious Diseases, Harvard Medical School Center for Global Health Delivery, Boston, MA.
  • Keshavjee S; TB Department, Harvard Medical School, Boston, MA, Infectious Diseases, Harvard Medical School Center for Global Health Delivery, Boston, MA, TB Department, Partners In Health, Boston, MA, Infectious Diseases, Brigham and Women´s Hospital, Boston, MA.
  • Becerra M; TB Department, Harvard Medical School, Boston, MA, Infectious Diseases, Harvard Medical School Center for Global Health Delivery, Boston, MA, TB Department, Partners In Health, Boston, MA, Infectious Diseases, Brigham and Women´s Hospital, Boston, MA.
  • Hussain H; TB Department, Interactive Research and Development (IRD) Global, Singapore.
  • Malik AA; TB Department, Interactive Research and Development (IRD) Global, Singapore, Internal Medicine, Yale School of Medicine, New Haven, CT, Yale Institute for Global Health, New Haven, CT, USA.
Int J Tuberc Lung Dis ; 26(8): 741-746, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35898140
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Isoniazida Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Isoniazida Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article